Weighted Average Number of Shares Outstanding, Diluted of ABEONA THERAPEUTICS INC. from 30 Jun 2010 to 31 Dec 2025

Taxonomy & unit
us-gaap: shares
Description
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Summary
ABEONA THERAPEUTICS INC. quarterly and annual Weighted Average Number of Shares Outstanding, Diluted in shares history and change rate from 30 Jun 2010 to 31 Dec 2025.
  • ABEONA THERAPEUTICS INC. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending 31 Dec 2025 was 66,135,821, a 61% increase year-over-year.
  • ABEONA THERAPEUTICS INC. annual Weighted Average Number of Shares Outstanding, Diluted for 2025 was 66,135,821, a 61% increase from 2024.
  • ABEONA THERAPEUTICS INC. annual Weighted Average Number of Shares Outstanding, Diluted for 2024 was 41,048,206, a 92% increase from 2023.
  • ABEONA THERAPEUTICS INC. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 21,380,476, a 172% increase from 2022.
Source SEC data
View on sec.gov
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Change (%)
Weighted Average Number of Shares Outstanding, Diluted, Annual (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Annual Change (%)

ABEONA THERAPEUTICS INC. Quarterly Weighted Average Number of Shares Outstanding, Diluted (shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q4 2025 66,135,821 +25,087,615 +61% 01 Oct 2025 31 Dec 2025 10-K 17 Mar 2026 2025 FY
Q3 2025 54,242,507 +6,160,749 +13% 01 Jul 2025 30 Sep 2025 10-Q 12 Nov 2025 2025 Q3
Q2 2025 66,640,620 +15,413,905 +30% 01 Apr 2025 30 Jun 2025 10-Q 14 Aug 2025 2025 Q2
Q1 2025 49,778,801 +22,463,264 +82% 01 Jan 2025 31 Mar 2025 10-Q 15 May 2025 2025 Q1
Q4 2024 41,048,206 +19,667,730 +92% 01 Oct 2024 31 Dec 2024 10-K 17 Mar 2026 2025 FY
Q3 2024 48,081,758 +23,284,194 +94% 01 Jul 2024 30 Sep 2024 10-Q 12 Nov 2025 2025 Q3
Q2 2024 51,226,715 +33,208,841 +184% 01 Apr 2024 30 Jun 2024 10-Q 14 Aug 2025 2025 Q2
Q1 2024 27,315,537 +10,411,513 +62% 01 Jan 2024 31 Mar 2024 10-Q 15 May 2025 2025 Q1
Q4 2023 21,380,476 01 Oct 2023 31 Dec 2023 10-K 20 Mar 2025 2024 FY
Q3 2023 24,797,564 +18,376,319 +286% 01 Jul 2023 30 Sep 2023 10-Q 14 Nov 2024 2024 Q3
Q2 2023 18,017,874 +12,211,401 +210% 01 Apr 2023 30 Jun 2023 10-Q 12 Aug 2024 2024 Q2
Q1 2023 16,904,024 01 Jan 2023 31 Mar 2023 10-Q 15 May 2024 2024 Q1
Q3 2022 6,421,245 01 Jul 2022 30 Sep 2022 10-Q 13 Nov 2023 2023 Q3
Q2 2022 5,806,473 01 Apr 2022 30 Jun 2022 10-Q 08 Aug 2023 2023 Q2
Q4 2014 1,942,905 +1,433,432 +281% 01 Oct 2014 31 Dec 2014 10-K 31 Mar 2015 2014 FY
Q3 2014 532,258 +23,603 +4.6% 01 Jul 2014 30 Sep 2014 10-Q 14 Nov 2014 2014 Q3
Q2 2014 26,191,311 +722,082 +2.8% 01 Apr 2014 30 Jun 2014 10-Q 14 Aug 2014 2014 Q2
Q1 2014 25,876,943 +720,742 +2.9% 01 Jan 2014 31 Mar 2014 10-Q 12 May 2014 2014 Q1
Q4 2013 509,473 -23,669,295 -98% 01 Oct 2013 31 Dec 2013 10-K 31 Mar 2015 2014 FY
Q3 2013 508,655 -23,665,050 -98% 01 Jul 2013 30 Sep 2013 10-Q 14 Nov 2014 2014 Q3
Q2 2013 25,469,229 +1,308,543 +5.4% 01 Apr 2013 30 Jun 2013 10-Q 14 Aug 2014 2014 Q2
Q1 2013 25,156,201 +1,010,713 +4.2% 01 Jan 2013 31 Mar 2013 10-Q 12 May 2014 2014 Q1
Q4 2012 24,178,768 01 Oct 2012 31 Dec 2012 10-K 26 Mar 2014 2013 FY
Q3 2012 24,173,705 01 Jul 2012 30 Sep 2012 10-Q 14 Nov 2013 2013 Q3
Q2 2012 24,160,686 +4,772,780 +25% 01 Apr 2012 30 Jun 2012 10-Q 14 Aug 2013 2013 Q2
Q1 2012 24,145,488 +4,903,918 +25% 01 Jan 2012 31 Mar 2012 10-Q 15 May 2013 2013 Q1
Q2 2011 19,387,906 -8,549,974 -31% 02 Apr 2011 30 Jun 2011 10-Q 15 Aug 2011 2011 Q2
Q1 2011 19,241,570 01 Jan 2011 31 Mar 2011 10-Q 15 May 2012 2012 Q1
Q2 2010 27,937,880 02 Apr 2010 30 Jun 2010 10-Q 15 Aug 2011 2011 Q2

ABEONA THERAPEUTICS INC. Annual Weighted Average Number of Shares Outstanding, Diluted (shares)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 66,135,821 +25,087,615 +61% 01 Jan 2025 31 Dec 2025 10-K 17 Mar 2026 2025 FY
2024 41,048,206 +19,667,730 +92% 01 Jan 2024 31 Dec 2024 10-K 17 Mar 2026 2025 FY
2023 21,380,476 +13,518,961 +172% 01 Jan 2023 31 Dec 2023 10-K 20 Mar 2025 2024 FY
2022 7,861,515 01 Jan 2022 31 Dec 2022 10-K 18 Mar 2024 2023 FY
2014 1,942,905 +1,433,432 +281% 01 Jan 2014 31 Dec 2014 10-K 31 Mar 2015 2014 FY
2013 509,473 -23,669,295 -98% 01 Jan 2013 31 Dec 2013 10-K 31 Mar 2015 2014 FY
2012 24,178,768 01 Jan 2012 31 Dec 2012 10-K 26 Mar 2014 2013 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.